ZINC SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zinc Sulfate, and what generic alternatives are available?
Zinc Sulfate is a drug marketed by Abraxis Pharm, Am Regent, Apotex, Fresenius Kabi Usa, Gland Pharma Ltd, Nivagen Pharms Inc, Somerset Theraps Llc, and Zydus Pharms. and is included in eight NDAs.
The generic ingredient in ZINC SULFATE is zinc sulfate. There are thirty-eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the zinc sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zinc Sulfate
A generic version of ZINC SULFATE was approved as zinc sulfate by AM REGENT on July 18th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZINC SULFATE?
- What are the global sales for ZINC SULFATE?
- What is Average Wholesale Price for ZINC SULFATE?
Summary for ZINC SULFATE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Clinical Trials: | 1,080 |
| Patent Applications: | 1,407 |
| Drug Sales Revenues: | Drug sales revenues for ZINC SULFATE |
| What excipients (inactive ingredients) are in ZINC SULFATE? | ZINC SULFATE excipients list |
| DailyMed Link: | ZINC SULFATE at DailyMed |
Recent Clinical Trials for ZINC SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| UNC Lineberger Comprehensive Cancer Center | Phase 1/Phase 2 |
| University Cancer Research Fund at Lineberger Comprehensive Cancer Center | Phase 1/Phase 2 |
| Bellicum Pharmaceuticals | Phase 1/Phase 2 |
Pharmacology for ZINC SULFATE
| Drug Class | Copper Absorption Inhibitor |
| Physiological Effect | Decreased Copper Ion Absorption |
Medical Subject Heading (MeSH) Categories for ZINC SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for ZINC SULFATE
US Patents and Regulatory Information for ZINC SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | ZINC SULFATE | zinc sulfate | INJECTABLE;INJECTION | 019229-002 | May 5, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 217074-001 | Aug 22, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Fresenius Kabi Usa | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 216145-002 | Dec 27, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Am Regent | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 209377-001 | Jul 18, 2019 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nivagen Pharms Inc | ZINC SULFATE | zinc sulfate | SOLUTION;INTRAVENOUS | 214597-001 | Jul 5, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
